The Lamkin Clinic, an Oklahoma-based provider of integrative, long-term healthcare solutions rooted in functional medicine, announced on Friday that those seeking help with depression or anxiety in Oklahoma can now benefit from a new, FDA-cleared, medication-free procedure.
According to the clinic, it is one of the first in Oklahoma to offer EXOMIND, a non-invasive brain stimulation treatment that is claimed to enhance mental wellness. With EXOMIND, an applicator delivers gentle magnetic pulses to stimulate or suppress brain activity, targeting areas involved in emotional regulation, cognitive function, and self-control. It is claimed that patients frequently report improved sleep quality, higher energy levels and enhanced emotional resilience. Clinical studies have also shown additional benefits such as reduced food cravings and an average weight loss after six treatments.
In addition, The Lamkin Clinic offers advanced therapies designed to support whole-body health and recovery such as growth hormone therapies, biotoxin illness, medical weight loss, thyroid optimization, platelet rich plasma therapy, incontinence, and many more.
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025